Outcomes measured at baseline and post-intervention included anthropometrics, liver enzymes, metabolic profile, hepatic steatosis (CAP score), inflammatory markers (TNF-α, MDA), antioxidant enzymes (SOD, CAT), and lifestyle behaviors (physical activity, sleep). This evidence concerns the gene SOD1 and fatty liver disease.